Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

HB 4544 (2025-2026)

https://ontology.bommaritollc.com/id/01a0d569-91db-74a2-bda8-948c2bb2cdad

adms:identifier	mi-legislature-measure 2025-2026/HB/4544
dcterms:temporal	Michigan Legislature, 2025-2026 session
in committee	House Committee on Government Operations (2025-2026)
primary sponsor	Matt Longjohn
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2025-HB-4544 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2025-HB-4544
schema:legislationIdentifier	HB 4544
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.en
schema:sponsor	Tyrone Carter Regina Weiss Natalie Price Tonya Myers Phillips Helena Scott Veronica Paiz Donavan McKinney Kimberly Edwards Mike McFall Erin Byrnes Stephanie A Young Jason M Hoskins Noah Arbit Kelly A Breen Jason Morgan Dylan Wegela Reggie Miller Jimmie Wilson Jr Morgan Foreman Joey Andrews Matt Longjohn Carrie Rheingans Jennifer Conlin Sharon MacDonell Denise Mentzer Jasper Martus Cynthia Neeley Julie Brixie Kara Hope Emily Dievendorf Phil Skaggs Stephen Wooden Carol Glanville Will Snyder Amos O'Neal Betsy Coffia
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2025-HB-4544
skos:prefLabel	HB 4544 (2025-2026)en
status	in committee
status date	2025-06-03xsd:date